Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt
· Delayed Price · Currency is EGP 1.180
-0.020 (-1.67%)
At close: Apr 28, 2026
EGX:MCRO Revenue
In the year 2025, Macro Group Pharmaceuticals (Macro Capital) S.A.E had annual revenue of 894.54M EGP with 72.04% growth. Macro Group Pharmaceuticals (Macro Capital) S.A.E had revenue of 216.28M in the quarter ending December 31, 2025, with 7.73% growth.
Revenue
894.54M
Revenue Growth
+72.04%
P/S Ratio
0.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
672.84M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Universal For Paper and Packaging Materials | 1.37B |
| Rubex International for Plastic and Acrylic Manufacturing | 388.58M |
| AlKhair River for Development Agricultural Investment and Environmental Services | 416.03M |
| Prime Holding S.A.E | 252.52M |
| Golden Textiles & Clothes Wool | 877.63M |
| Al Ahly for Development & Investment | 175.32M |
| Rakta Paper Manufacturing Company | 320.98K |
| Cairo Educational Services SAE | 146.76M |